Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Sobro in conjunction with its investment in Sluta Gräv AB
Mandate

Vinge advises Sobro in conjunction with its investment in Sluta Gräv AB

December 15, 2021 M&A EU, Competition and Regulatory Intellectual Property

Vinge has advised Sobro in conjunction with its investment in Sluta Gräv. As the new majority shareholder Sobro will continue the company’s fast expansion on the market together with the existing owners.

Sluta Gräv is an upstart in the construction industry, offering a modern and cost-effective ground anchoring with its own product-developed ground bolts. Sluta Gräv is an international actor which operates in 12 countries and has 150 authorised partners worldwide.

Vinge’s team primarily consisted of Johan Winnerblad, Carl Sander, Amanda Steen, Robin Fagerström, Johan Wahlbom, Fredrika Hjelmberg, Sofia Bergenstråhle, Felix Möller and Axel Lennartsson.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026